Thrombocytosis with acquired von Willebrand disease in an adolescent with sickle cell disease

Abstract Thrombocytosis is common in sickle cell disease and may contribute to vaso‐occlusion. Hydroxyurea treats extreme thrombocytosis. Acquired von Willebrand disease should be considered prior to aspirin therapy.

Bibliographic Details
Main Authors: Marianne E. M. Yee, Glaivy Batsuli, Satheesh Chonat, Sunita Park
Format: Article
Language:English
Published: Wiley 2021-01-01
Series:Clinical Case Reports
Subjects:
Online Access:https://doi.org/10.1002/ccr3.3556
id doaj-32f99e8b39c14174a1aa971f91ed327f
record_format Article
spelling doaj-32f99e8b39c14174a1aa971f91ed327f2021-05-21T11:05:45ZengWileyClinical Case Reports2050-09042021-01-019145746010.1002/ccr3.3556Thrombocytosis with acquired von Willebrand disease in an adolescent with sickle cell diseaseMarianne E. M. Yee0Glaivy Batsuli1Satheesh Chonat2Sunita Park3Aflac Cancer and Blood Disorders Center Children's Healthcare of Atlanta Atlanta GA USAAflac Cancer and Blood Disorders Center Children's Healthcare of Atlanta Atlanta GA USAAflac Cancer and Blood Disorders Center Children's Healthcare of Atlanta Atlanta GA USADepartment of Pathology and Laboratory Medicine Children's Healthcare of Atlanta Atlanta GA USAAbstract Thrombocytosis is common in sickle cell disease and may contribute to vaso‐occlusion. Hydroxyurea treats extreme thrombocytosis. Acquired von Willebrand disease should be considered prior to aspirin therapy.https://doi.org/10.1002/ccr3.3556acquired Von Willebrand diseasepriapismsickle cell diseasethrombocytosis
collection DOAJ
language English
format Article
sources DOAJ
author Marianne E. M. Yee
Glaivy Batsuli
Satheesh Chonat
Sunita Park
spellingShingle Marianne E. M. Yee
Glaivy Batsuli
Satheesh Chonat
Sunita Park
Thrombocytosis with acquired von Willebrand disease in an adolescent with sickle cell disease
Clinical Case Reports
acquired Von Willebrand disease
priapism
sickle cell disease
thrombocytosis
author_facet Marianne E. M. Yee
Glaivy Batsuli
Satheesh Chonat
Sunita Park
author_sort Marianne E. M. Yee
title Thrombocytosis with acquired von Willebrand disease in an adolescent with sickle cell disease
title_short Thrombocytosis with acquired von Willebrand disease in an adolescent with sickle cell disease
title_full Thrombocytosis with acquired von Willebrand disease in an adolescent with sickle cell disease
title_fullStr Thrombocytosis with acquired von Willebrand disease in an adolescent with sickle cell disease
title_full_unstemmed Thrombocytosis with acquired von Willebrand disease in an adolescent with sickle cell disease
title_sort thrombocytosis with acquired von willebrand disease in an adolescent with sickle cell disease
publisher Wiley
series Clinical Case Reports
issn 2050-0904
publishDate 2021-01-01
description Abstract Thrombocytosis is common in sickle cell disease and may contribute to vaso‐occlusion. Hydroxyurea treats extreme thrombocytosis. Acquired von Willebrand disease should be considered prior to aspirin therapy.
topic acquired Von Willebrand disease
priapism
sickle cell disease
thrombocytosis
url https://doi.org/10.1002/ccr3.3556
work_keys_str_mv AT marianneemyee thrombocytosiswithacquiredvonwillebranddiseaseinanadolescentwithsicklecelldisease
AT glaivybatsuli thrombocytosiswithacquiredvonwillebranddiseaseinanadolescentwithsicklecelldisease
AT satheeshchonat thrombocytosiswithacquiredvonwillebranddiseaseinanadolescentwithsicklecelldisease
AT sunitapark thrombocytosiswithacquiredvonwillebranddiseaseinanadolescentwithsicklecelldisease
_version_ 1721432178142740480